Aristolochia indica

Aristolochia indica is a traditional Siddha medicinal plant containing aristolochic acids that exhibits anti-inflammatory and antidiarrheal properties. The herb works by inhibiting mast cell degranulation and reducing inflammatory mediator release in tissues.

Origin & History

Aristolochia indica is a perennial climbing shrub native to India and tropical Asia, belonging to the Aristolochiaceae family, with roots traditionally used in herbal medicine. The plant is sourced from wild or cultivated roots, and extracts are typically prepared using ethanol, petroleum ether, ethyl acetate, or water via maceration or decoction methods.

Historical & Cultural Context

In Indian tribal systems, particularly among the Siddis and Gowlis tribes, A. indica roots have been used for skin diseases over generations. The plant features in global traditional herbal medicine practices for wounds, inflammation, and infections, with historical documentation in ethnobotanical records.

Health Benefits

• Anti-inflammatory effects: Reduced rat paw edema and mast cell degranulation by 67% at 150-300 mg/kg doses (preliminary animal evidence)
• Antidiarrheal activity: Significantly reduced diarrhea frequency and intestinal transit in mice at 200-400 mg/kg doses (preliminary animal evidence)
• Fibrinolytic properties: Root enzyme degraded fibrin-β amyloid aggregates more potently than plasmin in rat models (preliminary in vitro evidence)
• Anti-anaphylactic effects: Dose-dependent mortality reduction in animal models at 50-1000 mg/kg (preliminary animal evidence)
• Mast cell stabilization: Inhibited degranulation to 32% vs 100% control at 300 mg/kg (preliminary animal evidence)

How It Works

Aristolochia indica contains aristolochic acids that inhibit mast cell degranulation and reduce histamine release, contributing to its anti-inflammatory effects. The herb appears to modulate intestinal motility and reduce prostaglandin synthesis pathways. These bioactive compounds may also interfere with cyclooxygenase enzymes to decrease inflammatory mediator production.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Aristolochia indica; all evidence is limited to preclinical animal and in vitro studies. Key studies include rat inflammation models showing 67% reduction in mast cell degranulation (PMID: 23543848), mouse antidiarrheal studies (PMID: 24744636), and rat fibrinolytic enzyme research (PMID: 26545113).

Clinical Summary

Current evidence for Aristolochia indica comes exclusively from preliminary animal studies with no human clinical trials available. Anti-inflammatory effects were demonstrated in rat models showing 67% reduction in paw edema at doses of 150-300 mg/kg. Antidiarrheal activity was observed in mice at 200-400 mg/kg doses with significant reductions in diarrhea frequency and intestinal transit time. The evidence quality remains limited due to small sample sizes and lack of human data.

Nutritional Profile

Aristolochia indica is a medicinal plant with limited conventional nutritional characterization; it is not consumed as a dietary food source. Known bioactive compounds drive its pharmacological profile: (1) Aristolochic acids (AA-I and AA-II) — the primary alkaloids, present at approximately 0.1–0.5% dry weight in roots and stems; AA-I typically predominates; these are nephrotoxic and carcinogenic nitrophenanthrene compounds with very low safe exposure thresholds. (2) Aristolactams — secondary alkaloids including aristolactam AII and BII, detected in root and aerial parts at trace-to-low concentrations (~0.05–0.2% dry weight). (3) Terpenoids — including lupeol and β-sitosterol, present in root extracts; β-sitosterol reported at approximately 0.3–0.8% of lipid fraction. (4) Flavonoids — quercetin and kaempferol derivatives detected in leaf extracts at roughly 0.4–1.2 mg/g dry weight. (5) Phenolic acids — including caffeic acid and chlorogenic acid at approximately 0.2–0.6 mg/g dry weight. (6) A fibrinolytic enzyme (serine protease class) isolated from roots, molecular weight approximately 23–25 kDa, demonstrated in vitro activity against fibrin-β amyloid. (7) Tannins — condensed tannins estimated at 1.5–3% dry weight in bark/root. Macronutrient data is not formally established; crude fiber content in dried root material is estimated at 8–15% based on related Aristolochia species. Mineral content is incompletely characterized; trace potassium, calcium, and magnesium are present but not quantified in standardized studies. Bioavailability note: Aristolochic acids are rapidly absorbed orally and form stable DNA adducts in renal tissue; even low-dose chronic exposure carries documented carcinogenic risk, making nutritional use contraindicated.

Preparation & Dosage

No clinically studied human dosages exist. Animal studies used root extracts at: 150-300 mg/kg ethanol extract for anti-inflammatory effects, 200-400 mg/kg for antidiarrheal activity, and 50-1000 mg/kg for anti-anaphylactic effects. No standardization specified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Boswellia serrata, Ginger, Quercetin, Bromelain

Safety & Interactions

Aristolochia species contain aristolochic acids that are associated with serious kidney toxicity and increased cancer risk in humans. Long-term use has been linked to aristolochic acid nephropathy and urothelial carcinomas. The herb should be avoided during pregnancy and breastfeeding due to potential teratogenic effects. No specific drug interactions have been documented, but caution is advised with nephrotoxic medications.